Webinar title: Heart, Kidney, Metabolism: Connecting the Dots on Cardiovascular Kidney Metabolic Syndrome
Speaker: Dr. Levette Owusu-Ansah, PharmD, BCGP, Cardiometabolic Pharmacology
Dr. Levette Owusu-Ansah is a board-certified pharmacist and healthcare leader with 27 years of experience across hospital, community, and long-term care pharmacy. She currently serves as Health Systems Director of Pharmacy for The Methodist Hospitals in Indiana. Passionate about healthcare innovation, education, and mentorship, she is committed to advancing pharmacy practice and developing future healthcare professionals. She is also cofounder of Eagle Eye Healthcare Solutions, focused on metabolic health and wellness, and serves as a non-affiliate member of Chicago State University’s Institutional Biosafety Committee. Her life and leadership are grounded in her love for Christ, community, and family.
Objectives:
• Define CKM syndrome and apply the AHA 5-stage (0–4) staging framework to a patient presentation.
• Describe the pathophysiologic links among adiposity, insulin resistance, CKD, and cardiovascular disease.
• Explain the evidence for lifestyle medicine as foundational, disease-modifying therapy across every CKM stage
• Select guideline-directed pharmacotherapy by CKM stage and organ-protective indication, citing landmark trials
• Describe how lifestyle and pharmacotherapy act synergistically within an integrated, stage-based algorithm .
• Identify the team approach role in screening, medication optimization, and interdisciplinary CKM care.
Date: Thursday, 29th of October 2026
Time: 2:00PM EST / 9:00PM EAT/ 8:00PM CAT / 7:00PM WAT
Duration: 60 minutes